SARCOIDOSIS: PROBLEMS IN CLASSIFICATION

Cover Page


Cite item

Full Text

Abstract

In this article the authors discuss the issues related to assessment of activity and severity of sarcoidosis, course and radiographic manifestations of this disease. Problems in defining of different forms of sarcoidosis resulted in suggestion of new version of classification.

About the authors

S. A. Terpigoev

Moscow Regional Research Clinical Institute named after M.F. Vladimirskiy

Author for correspondence.
Email: smith42@yandex.ru
кандидат медицинских наук, старший научный сотрудник кардипульмоноло- гического отделения ГБУЗ МО Московского областного научно-исследовательского клинического института им. М.Ф. Владимирского Адрес: 129110, Москва, ул. Щепкина, д. 61/2 Тел.: (495) 631-72-86 Россия

B. A. El-Zein

I.M. Sechenov First Moscow State Medical University

Email: smith42@yandex.ru
аспирант кафедры пульмонологии ГБОУ ВПО Первый Московский государственный меди- цинский университет им. И.М. Сеченова Минздравсоцразвития России Адрес: 129110, Москва, ул. Щепкина, д. 61/2

V. M. Vereshchagina

Moscow Regional Research Clinical Institute named after M.F. Vladimirskiy

Email: smith42@yandex.ru
доктор медицинских наук, ведущий научный сотрудник клинической лабо- ратории ГБУЗ МО Московского областного научно-исследовательского клинического института им. М.Ф. Владимирского Адрес: 129110, Москва, ул. Щепкина, д. 61/2 Россия

N. R. Paleev

Moscow Regional Research Clinical Institute named after M.F. Vladimirskiy

Email: smith42@yandex.ru
академик РАМН, профессор, доктор медицинских наук, заведующий кафедры терапии ГБУЗ МО Московского областного научно-исследовательского клинического института им. М.Ф. Владимирского Адрес: 129110, Москва, ул. Щепкина, д. 61/2 Россия

References

  1. Bargagli E., Mazzi A., Rottoli P. Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clinics in Chest Medicine. 2008; 29: 445–458.
  2. Baughman R., Lower E., du Bois R. Sarcoidosis. Lancet. 2003; 361: 1111–1118.
  3. Drent M., Costabel U. Sarcoidosis. Eur. Resp. Monograph. 2005; 32: 259–266.
  4. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Resp. Crit. Care Med. 1999; 160 (2): 736–755.
  5. James G. Sarcoidosis. Postgrad. Ed. J. 2001; 77: 177–180.
  6. Sarqoidoz: ot gipotezy` q praqtiqe / Pod red. A.A. Wizelia. Kazan`: Izdatel`stvo «FE`N», Aqademiia nauq RT. 2004. 348.
  7. Dmitrieva L.I., Stepanian I.E`. Sarqoidoz organov dy`haniia: voprosy` e`tiologii, patogeneza, classifiqatciia, rentgenodiagnostiqa. Vestn. rentgenologii i radiologii. 1998; 4: 33–39.
  8. Sarqoidoz / Pod red. A.G. Homenqo, O. Shvai`gera. M.: Meditcina. 1982. 292.
  9. Sarqoidoz: uch.-metod. posobie dlia slushatelei poslevuzowsqogo i dopolnitel`nogo prof. obrazovaniia / Pod red. A.G. Chuchalina. Kazan`. 2010. 58.
  10. Sarqoidoz: monografiia / Pod red. A.A. Wizelia. M.: Atmosfera. 2010. 416.
  11. Sharma R., Guleria R., Mohan A., Das C. Scadding criteria for diagnosis of sarcoidosis: is there a need for change? Chest. 2004; 126: 754.
  12. Lynch J., Ling Y., Koss M., White E. Pulmonary sarcoidosis. Semin. Resp. Crit. Care Med. 2007; 28: 53–74.
  13. Nagai S., Handa T., Ito Y. et al. Outcome of sarcoidosis. Clin. Chest Med. 2008; 29: 565–574.
  14. Bargagli E., Mazzi A., Rottoli P. Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin. Chest Med. 2008; 29: 445–458.
  15. Siltzbah L. Current thoughts on the epidemiology and etiology of sarcoidosis. Am. J. Med. 1965; 39: 361–368.
  16. Siltzbah L. Sarcoidosis: clinical features and management. Med. Clin. North Am, 1967; 51: 483–502.
  17. Katz S. Clinical presentation and natural history of sarcoidosis / B. Fanburg (ed.). Sarcoidosis and other granulomatous diseases of the lung. N.-Y.: Marcel Dekker. 1983. 3–36.
  18. Sipahi Demirkok S., Basaranoglu M., Dervis E. et al. Analysis of 87 patients with Lofgren’s syndrome and the pattern of seasonality of subacute sarcoidosis. Respirology. 2006; 4: 456–461.
  19. Porter N., Beynon H., Randeva H. Endocrine and reproductive manifestations of sarcoidosis. Q. J. Med. 2003; 8: 553–561.
  20. Martinetti M., Tinelli C., Kolek V. et al. The sarcoidosis map. A joint survey of clinical and immunogenetic findings in two European countries. Am. J. Resp. Crit. Care Med. 1995; 152: 557–64.
  21. Consensus conference: activity of sarcoidosis. Eur. Resp. J. 1994; 7: 624–627.
  22. Shimada T., Shimada K., Sakane T. et al. Diagnosis of cardiac sarcoidosis and the evaluation of the effect of steroid therapy by Gadolinium-DTPA-enhanced magnetic resonance imaging. Am. J. Med. 2001; 110: 520–527.
  23. Hoitsma E., Sharma O. Neurosarcoidosis. Eur. Resp. Mon, 2005; 32: 164–187.
  24. Gerke A., Hunninghake G.. The immunology of sarcoidosis. Clin. Chest Med. 2008; 29: 379–390.
  25. Rothkrantz-Kos S., van Dieijen-Visser M., Mulder P. et al. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin. Chem. 2003; 49: 1510–1517.
  26. Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur. Resp. J. 1998; 12: 716–738.
  27. Grutters J., Fellrath J.-M., Mulder L. et al. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis. Chest. 2003; 124: 186–195.
  28. Johansen J., Milman N., Hansen M. et al. Increased serum YKL- 40 in patients with pulmonary sarcoidosis — a potential marker of disease activity? Resp. Med. 2005; 99: 396–402.
  29. Dai H., Guzman J., Costabel U. Increased expression of apoptosis signaling receptors by alveolar macrophages in sarcoidosis. Eur. Resp. J. 1999; 13: 1451–1454.
  30. Judson M., Baughman R., Teirstein A. et al. Defining organ involvement in sarcoidosis: the ACCESS propose instrument. Sarcoidosis Vasc. Diffuse Lung Dis. 1999; 16: 75–86.
  31. Wasfi Y., Rose C., Murphy J. et al. A new tool to assess sarcoidosis severity. Chest. 2010; 129: 1234–1245.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies